New 52 Week High Today

SIGA Technologies Inc SIGA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
10.24quote price arrow up+0.09 (+0.89%)
Volume
31,452
Close
10.15quote price arrow up+0.71 (+7.52%)
Volume
1,062,883
52 week range
3.93 - 10.21
Loading...
  • Open9.50
  • Day High10.21
  • Day Low9.50
  • Prev Close9.44
  • 52 Week High10.21
  • 52 Week High Date05/03/24
  • 52 Week Low3.93
  • 52 Week Low Date09/12/23

Key Stats

  • Market Cap721.58M
  • Shares Out71.09M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change81.25

KEY STATS

  • Open9.50
  • Day High10.21
  • Day Low9.50
  • Prev Close9.44
  • 52 Week High10.21
  • 52 Week High Date05/03/24
  • 52 Week Low3.93
  • 52 Week Low Date09/12/23
  • Market Cap721.58M
  • Shares Out71.09M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change81.25

RATIOS/PROFITABILITY

  • EPS (TTM)0.94
  • P/E (TTM)10.80
  • Fwd P/E (NTM)-
  • EBITDA (TTM)84.826M
  • ROE (TTM)37.09%
  • Revenue (TTM)139.917M
  • Gross Margin (TTM)87.69%
  • Net Margin (TTM)48.65%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date03/25/2024
  • Div Amount0.60
  • Split Date-
  • Split Factor-

Latest On SIGA Technologies Inc

 

Profile

MORE
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox...
Diem Nguyen Ph.D.
Chief Executive Officer, Director
Daniel Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Dennis Hruby Ph.D.
Executive Vice President, Chief Scientific Officer
Jay Varma M.D.
Executive Vice President, Chief Medical Officer, Director
Address
31 East 62Nd Street
New York, NY
10065
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
2.08+0.02+0.97%
OCUL
Ocular Therapeutix Inc
6.17+0.30+5.11%
HROW
Harrow Inc
10.38-0.26-2.44%
CSTL
Castle Biosciences Inc
24.33+1.49+6.52%
CDXC
Chromadex Corp
3.78+0.02+0.53%